Filing Details

Accession Number:
0000899243-19-027116
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-12 16:17:40
Reporting Period:
2019-11-12
Accepted Time:
2019-11-12 16:17:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563577 Galera Therapeutics Inc. GRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202793 Michael Powell C/o Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
Yes No Yes No
1245624 James Healy C/o Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
No No Yes No
1590102 Anand Mehra C/o Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
No No Yes No
1612133 Sofinnova Venture Partners Ix, L.p. C/o Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
No No Yes No
1612134 Sofinnova Management Ix, L.l.c. C/o Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-12 2,333,712 $0.00 2,333,712 No 4 C Direct
Common Stock Acquisiton 2019-11-12 750,000 $12.00 3,083,712 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B-2 Preferred Stock Disposition 2019-11-12 9,090,909 $0.00 1,797,843 $0.00
Common Stock Series C Preferred Stock Disposition 2019-11-12 2,709,659 $0.00 535,869 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis.
  2. The shares reported herein are held of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Dr. Michael F. Powell, Dr. James Healy and Dr. Anand Mehra are the managing members of Sofinnova Management IX, L.L.C., the general partner of SVP IX, and as such, may be deemed to share voting and investment power with respect to such shares. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of such reporting person's pecuniary interest therein.